Vistagen Therapeutics Inc (VTGN)
4.59
-0.13
(-2.75%)
USD |
NASDAQ |
Apr 25, 10:21
Vistagen Therapeutics Profit Margin (Quarterly): -1.54K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -1.54K% |
September 30, 2023 | -2.37K% |
June 30, 2023 | -3.89K% |
March 31, 2023 | -6.96K% |
December 31, 2022 | -5.43K% |
September 30, 2022 | |
June 30, 2022 | -6.38K% |
March 31, 2022 | -42.90K% |
December 31, 2021 | -2.94K% |
September 30, 2021 | -3.57K% |
June 30, 2021 | -2.19K% |
March 31, 2021 | -1.41K% |
December 31, 2020 | -1.69K% |
September 30, 2020 | -987.4% |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 |
Date | Value |
---|---|
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | -211.1% |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | -911.1% |
March 31, 2012 | -648.8% |
December 31, 2011 | -187.5K% |
September 30, 2011 | -713.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-42.90K%
Minimum
Mar 2022
-987.4%
Maximum
Sep 2020
-6.33K%
Average
-2.94K%
Median
Dec 2021
Profit Margin (Quarterly) Benchmarks
Ardelyx Inc | -83.82% |
Axsome Therapeutics Inc | -137.9% |
Vir Biotechnology Inc | -1.21K% |
Immuneering Corp | -- |
NovaBay Pharmaceuticals Inc | -110.2% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -80.76% |
Return on Assets | -67.06% |
Return on Invested Capital | -80.23% |
Operating Margin (Quarterly) | -1.92K% |
Return on Net Operating Assets | -975.0% |